Titre:
  • Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: Analysis from the ALTTO (BIG 2-06) trial
Auteur:Lambertini, Matteo; Agbor-Tarh, Dominique; Metzger-Filho, Otto; Pondé, Noam; Poggio, Francesca; Hilbers, Florentine FS; Korde, Larissa; Chumsri, Saranya; Werner, Olena; Del Mastro, Lucia; Caparica Bitton, Rafael; Moebus, Volker; Moreno-Aspitia, Alvaro; Piccart-Gebhart, Martine; Azambuja, Evandro
Informations sur la publication:ESMO Open, 5, 6, e000979
Statut de publication:Publié, 2020-11
Sujet CREF:Généralités
Mots-clés:adjuvant therapy
breast cancer
HER2-positive
prognosis
trastuzumab
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2059-7029
info:doi/10.1136/esmoopen-2020-000979
info:scp/85095766844
info:pmid/33154022